BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37173391)

  • 1. The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma.
    Wang S; Wang T; Zhang X; Cheng S; Chen C; Yang G; Wang F; Wang R; Zhang Q; Yang D; Zhang Y; Liu S; Qin H; Liu Q; Liu H
    Cell Death Differ; 2023 Jul; 30(7):1757-1770. PubMed ID: 37173391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.
    Liu C; Chen Z; Ding X; Qiao Y; Li B
    Lab Invest; 2022 May; 102(5):524-533. PubMed ID: 35022505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin.
    Tang Z; Jiang W; Mao M; Zhao J; Chen J; Cheng N
    Clin Transl Med; 2021 Apr; 11(4):e390. PubMed ID: 33931967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP35 mitigates endoplasmic reticulum stress-induced apoptosis by stabilizing RRBP1 in non-small cell lung cancer.
    Wang W; Wang M; Xiao Y; Wang Y; Ma L; Guo L; Wu X; Lin X; Zhang P
    Mol Oncol; 2022 Apr; 16(7):1572-1590. PubMed ID: 34618999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2.
    Liu C; Wang L; Chen W; Zhao S; Yin C; Lin Y; Jiang A; Zhang P
    Oncotarget; 2015 Sep; 6(29):27891-906. PubMed ID: 26348204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
    Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
    Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of survivin protein stability by USP35 is evolutionarily conserved.
    Wang W; Lin H; Zheng E; Hou Z; Liu Y; Huang W; Chen D; Feng J; Li J; Li L
    Biochem Biophys Res Commun; 2021 Oct; 574():48-55. PubMed ID: 34438346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma.
    Yu YP; Cai LC; Wang XY; Cheng SY; Zhang DM; Jian WG; Wang TD; Yang JK; Yang KB; Zhang C
    Cancer Sci; 2020 May; 111(5):1555-1566. PubMed ID: 32128917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP35 promotes HCC development by stabilizing ABHD17C and activating the PI3K/AKT signaling pathway.
    Wang L; Wang J; Ma X; Ju G; Shi C; Wang W; Wu J
    Cell Death Discov; 2023 Nov; 9(1):421. PubMed ID: 37993419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway.
    Duan J; Jin M; Yang D; Shi J; Gao J; Guo D; Tang H; Zhang S; Qiao B
    Bioengineered; 2022 Feb; 13(2):4455-4467. PubMed ID: 35152855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation.
    Lv T; Zhang B; Jiang C; Zeng Q; Yang J; Zhou Y
    Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
    Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
    Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan Oligosaccharides Induce Apoptosis in Human Renal Carcinoma via Reactive-Oxygen-Species-Dependent Endoplasmic Reticulum Stress.
    Zhai X; Yuan S; Yang X; Zou P; Li L; Li G; Shao Y; Abd El-Aty AM; Hacımüftüoğlu A; Wang J
    J Agric Food Chem; 2019 Feb; 67(6):1691-1701. PubMed ID: 30658530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer.
    Zhang J; Chen Y; Chen X; Zhang W; Zhao L; Weng L; Tian H; Wu Z; Tan X; Ge X; Wang P; Fang L
    Cell Death Differ; 2021 Jan; 28(1):139-155. PubMed ID: 32678307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Keap1 contributes to poor prognosis and Axitinib resistance of renal cell carcinoma via upregulation of Nrf2 expression.
    Huang H; Wu Y; Fu W; Wang X; Zhou L; Xu X; Huang F; Wu Y
    Int J Mol Med; 2019 May; 43(5):2044-2054. PubMed ID: 30896860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP35, regulated by estrogen and AKT, promotes breast tumorigenesis by stabilizing and enhancing transcriptional activity of estrogen receptor α.
    Cao J; Wu D; Wu G; Wang Y; Ren T; Wang Y; Lv Y; Sun W; Wang J; Qian C; He L; Yang K; Li H; Gu H
    Cell Death Dis; 2021 Jun; 12(6):619. PubMed ID: 34131114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
    Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
    Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.
    Wang J; Wang C; Xu P; Li X; Lu Y; Jin D; Yin X; Jiang H; Huang J; Xiong H; Ye F; Jin J; Chen Y; Xie Y; Chen Z; Ding H; Zhang H; Liu R; Jiang H; Chen K; Yao Z; Luo C; Huang Y; Zhang Y; Zhang J
    Theranostics; 2021; 11(11):5387-5403. PubMed ID: 33859753
    [No Abstract]   [Full Text] [Related]  

  • 20. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
    Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
    J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.